Companies / Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

NYSE: LCTXCIK 876343CARLSBAD, CAlineagecell.com ↗

Financials · FY2025

Revenue$14.56M
Net income$-63.53M
Total debt—
Cash$37.35M
Diluted EPS$-0.28
Shares outstanding252.9M

Ownership

252.9M shares outstanding · as of Aug 3, 2026
0.11%Insiders
Ownership
Insiders0.11%286,579
Institutions46.26%116,987,628
Public float53.63%135,633,257

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Culley Brian MCEOPresident and CEO · Director
0.10%255,516
Samuel George A. IIIGeneral Counsel and Secretary
0.01%31,063
Howe Jill AnnChief Financial Officer
——

Institutional holders 124

View all →
HolderValue% of shares
Broadwood Capital Inc$78.31M19.60%
BlackRock, Inc.$17.27M5.21%
Vanguard Group Inc$16.11M3.81%
Defender Capital, LLC.$11.41M2.70%
Millennium Management LLC$8.79M2.20%
Raffles Associates LP$8.47M2.12%
Comerica Bank$7.68M1.82%
Marshall Wace, LLP$4.84M1.21%
Geode Capital Management, LLC$3.99M1.00%
Renaissance Technologies LLC$3.36M0.84%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 12, 2026Culley Brian M
CEO
BuyCommon Shares$24.4K+15K
+6.24%
255,516
0.10% of shares
low
Feb 11, 2026Culley Brian M
CEO
OtherCommon Shares$23.2K-13K
-5.08%
240,516
0.10% of shares
low
Feb 11, 2026Samuel George A. III
Executive
OtherCommon Shares$4.5K-3K
-7.45%
31,063
0.01% of shares
low
Mar 5, 2026Howe Jill Ann
Executive
GrantEmployee Stock Option (Right to Buy)—+1.1M
1,050,000
0.42% of shares
low
Mar 5, 2026Samuel George A. III
Executive
GrantEmployee Stock Option (Right to Buy)—+900K
900,000
0.36% of shares
low
Feb 11, 2026Samuel George A. III
Executive
ExerciseRestricted Stock Units—-6K
-100.00%
0
0.00% of shares
low
Feb 11, 2026Samuel George A. III
Executive
ExerciseCommon Shares—+6K
+22.10%
33,565
0.01% of shares
low
Mar 5, 2026Culley Brian M
CEO
GrantEmployee Stock Option (Right to Buy)—+3.3M
3,250,000
1.29% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LCTXCommon StockEquity53566P109BBG000G8RJY6